发明名称 |
IFG-1 to improve neural outcome |
摘要 |
A method of treating injuries to or diseases of the central nervous system that predominantly effects glia and/or non-cholinergic neuronal cells characterized in that it comprises the step of increasing the active concentration(s) of insulin-like growth factor 1 and/or analogues thereof in the central nervous system of the patient. The present invention also provides therapeutic compositions comprising insulin-like growth factor 1 and/or analogues thereof for administration to a patient at or following a neural insult, which compositions are useful in minimizing damage to the central nervous system that would otherwise occur following the insult.
|
申请公布号 |
US5714460(A) |
申请公布日期 |
1998.02.03 |
申请号 |
US19950460365 |
申请日期 |
1995.06.02 |
申请人 |
GENENTECH INC.;AUCKLAND UNISERVICES LIMITED |
发明人 |
GLUCKMAN, PETER;NIKOLICS, KAROLY |
分类号 |
A61K9/00;A61K38/30;(IPC1-7):A61K38/28 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|